https://www.selleckchem.com/pr....oducts/1-methyl-3-ni
05 was considered statistically significant. We analyzed the data of 110 patients 55 in Group X and 55 in Group E. The two groups did not have different bleeding incidence (56.4% vs 60.0%; P = 0.7; however, the incidence of severe bleeding was less with xylometazoline than with epinephrine (3.63% vs 14.54%; P 0.05). We also observed less bleeding during extubation (38.2% vs 68.5%; P 0.05) with xylometazoline. Other secondary outcomes were akin to both groups. The incidence of severe and post-extub
Like
Comment
Share
